Trials / Completed
CompletedNCT07097610
The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents
The Effect of Mosaic Puzzle Game on Nomophobia in Adolescents: A Randomised Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Rabia Nur TEKİ KESKİN · Academic / Other
- Sex
- All
- Age
- 12 Years – 14 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate the effect of mosaic puzzle application on nomophobia in middle school children aged 12-14. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks, at a time deemed appropriate by the school and under the supervision of the researcher. The control group children will not be given any intervention; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study. Hypothesis 1: The intervention group's level of nomophobia is lower than that of the control group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Mosaic Puzzle Intervention | This study aims to investigate the effect of mosaic puzzle application on nomophobia in adolescents. The data for the study will be collected over a 5-week period. The experimental group children will be asked to play mosaic puzzle games for 1 hour, 2 days a week for 5 weeks at a time deemed appropriate by the school under the supervision of the researcher. The control group children will not be given any application; they will only be observed, and a final test will be administered at the end of the 5 weeks. The study is planned as a single-center study, and a total of 30 children aged 12-14 with a nomophobia scale score of 60 or higher who meet the inclusion criteria will be included in the study. |
Timeline
- Start date
- 2025-02-15
- Primary completion
- 2025-03-15
- Completion
- 2025-05-25
- First posted
- 2025-07-31
- Last updated
- 2025-07-31
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07097610. Inclusion in this directory is not an endorsement.